Results 41 to 50 of about 119,863 (250)

Implications of prioritizing HIV cure: new momentum to overcome old challenges in HIV. [PDF]

, 2016
BACKGROUND: Curing HIV is a new strategic priority for several major AIDS organizations. In step with this new priority, HIV cure research and related programs are advancing in low, middle, and high-income country settings.
Gilbertson, Adam, Lo, Ying-Ru, Tucker, Joseph D, Vitória, Marco   +3 more
core   +3 more sources

Synergies, tensions and challenges in HIV prevention, treatment and cure research: exploratory conversations with HIV experts in South Africa [PDF]

, 2016
Background: The ethical concerns associated with HIV prevention and treatment research have been widely explored in South Africa over the past 3 decades.
A Van der Straten, A Violari, B Auvert, B Lo, C Bateman, C Campbell, C Chu, C Kapp, C Kapp, C Staunton, C Worthington, Christopher J. Colvin, Ciara Staunton, D Cooper, E Obadare, G Henderson, G Hütter, G Ramjee, G Ramjee, H Peay, H Schneider, J Amon, J Ananworanich, J Cohen, J Lawrence, J McMahon, J Smetherham, J Sugarman, J Tucker, J Wreford, K Dube, K MacQueen, K Mayer, K Moodley, K Moodley, Keymanthri Moodley, L Van Damme, M Cohen, M Thamm, N Bolognesi, N Eyal, P Applebaum, P Lurie, P Sidley, P Sidley, P Volberding, Q Karim, R Cassidy, R Inoyori, R Johnston, RE Roddy, S Deeks, S Horng, S Rennie, S Rennie, Theresa Rossouw, W El-Sadr, WH Organisation, Y Lo   +58 more
core   +6 more sources

The significance and expectations of HIV cure research among people living with HIV in Australia.

PLoS ONE, 2020
Most people living with HIV (PLHIV) with reliable access to antiretroviral treatment (ART) have a life expectancy similar to uninfected populations. Despite this, HIV can negatively affect their social and psychological wellbeing.
Jennifer Power, Gary W Dowsett, Andrew Westle, Joseph D Tucker, Sophie Hill, Jeremy Sugarman, Sharon R Lewin, Graham Brown, Jayne Lucke   +8 more
doaj   +1 more source

Biomarker reveals HIV's hidden reservoir. [PDF]

, 2014
Determining the total amount of HIV DNA in people undergoing antiretroviral therapy could accelerate the development of novel therapies and potential cures for HIV ...
Cockerham, Leslie R, Deeks, Steven G
core   +2 more sources

Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States

BMC Medical Ethics, 2022
Background HIV cure research involving cell and gene therapy has intensified in recent years. There is a growing need to identify ethical standards and safeguards to ensure cell and gene therapy (CGT) HIV cure research remains valued and acceptable to as
Karine Dubé, John Kanazawa, Hursch Patel, Michael Louella, Laurie Sylla, Jeff Sheehy, Lynda Dee, Jeff Taylor, Jen Adair, Kim Anthony-Gonda, Boro Dropulić, John A. Sauceda, Michael J. Peluso, Steven G. Deeks, Jane Simoni   +14 more
doaj   +1 more source

Interventions for neurocognitive dysfunction [PDF]

, 2017
Purpose of review: To evaluate current barriers to HIV cure strategies and interventions for neurocognitive dysfunction with a particular focus on recent advancements over the last three years. Recent findings: Optimal anti-retroviral therapy (ART) poses
Brew, B, Ellero, J, Lubomski, M
core   +2 more sources

Access to HIV prevention and care for HIV-exposed and HIV-infected children : a qualitative study in rural and urban Mozambique [PDF]

, 2014
Background: Follow-up of HIV-exposed children for the delivery of prevention of mother-to-child transmission services and for early diagnosis and treatment of HIV infection is critical to their survival.
Bobrow, Emily A, De Schacht, Caroline, Dimande, Stelio A, Gill, Michelle, Guay, Laura, Lucas, Carlota, Macasse, Eugenia, Mboa, Catarina   +7 more
core   +2 more sources

A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of HIV Infection. [PDF]

, 2006
BACKGROUND: Antimonials are the mainstay of visceral leishmaniasis (VL) treatment in Africa. The increasing incidence of human immunodeficiency virus (HIV) coinfection requires alternative safe and effective drug regimens.
Abren Dejenie, Davidson RN, Delgado J, Gerry Boots, Jo Mesure, Koert Ritmeijer, Kuhlencord A, Margriet den Boer, Medrano FJ, Meredith SE, Molina R, Robert N. Davidson, Sundar S, Tadesse Beyene Hundie, Yibeltal Assefa   +14 more
core   +2 more sources

Navigating multiple sources of healing in the context of HIV/AIDS and wide availability of antiretroviral treatment: a qualitative study of community participants’ perceptions and experiences in rural South Africa [PDF]

, 2018
Background: South Africa introduced the world’s largest antiretroviral treatment (ART) program in 2004 and since 2016 the Department of Health implemented a universal Treatment as Prevention (TasP) strategy.
Moshabela, Mosa, Rochat, Tamsen, Wight, Daniel, Zuma, Thembelihle   +3 more
core   +1 more source

Integrating tuberculosis and HIV care in the primary care setting in South Africa. [PDF]

, 2004
BACKGROUND: In many countries including South Africa, the increasing human immunodeficiency virus (HIV) and tuberculosis (TB) epidemics have impacted significantly on already weakened public health services.
Anderson SR, Cantwell MF, Godfrey-Faussett P, Maher D, Rieder HL, World Health Organization   +5 more
core   +2 more sources